The aim of the study was to evaluate the clinical performance of FTD SARS-CoV-2 compared to the RealStar RT-PCR kit 1.0. The analysis of 100 nasopharyngeal swabs showed an overall agreement of 88 %. The positive percentage agreement was 85.6 % and the negative percentage agreement was 91 %. In conclusion we observed a substantial agreement among the two methods, with discrepancies mainly observed in specimens with relatively low amount of viral RNA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420089 | PMC |
http://dx.doi.org/10.1016/j.jviromet.2021.114276 | DOI Listing |
Transfusion
January 2025
Department of Research, Sanquin Blood Supply Foudation, Amsterdam, The Netherlands.
Pathogens
August 2024
Campus Santé Timone, Aix Marseille University, AP-HM, SSA, RITMES, 13005 Marseille, France.
Microorganisms
August 2024
Clinical Pathology Department, National Cancer Institute, Cairo University, Cairo 11796, Egypt.
This study aimed to investigate LRTIs in cancer patients, focusing on pathogen distribution, and outcomes based on tumor types and antimicrobial treatments. The study included 110 cancer patients exhibiting symptoms of lower respiratory tract infections (LRTIs), consisting of 67 males and 43 females across a wide age range from under 1 year to over 60 years old. Exclusion of SARS-CoV-2 infection was conducted before admission.
View Article and Find Full Text PDFHeliyon
April 2024
Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco.
Background: The prevalence of respiratory infections is largely underexplored in Kuwait. The aim of our study is to determine the etiology of infections from patients who are SARS-CoV-2 negative hospitalized with severe lower respiratory tract infections (LRTIs) in Kuwait during the coronavirus disease 2019 (COVID-19) pandemic.
Methods: We conducted an observational cross-sectional study among severe LRTI patients between September 2021 and March 2022.
Influenza Other Respir Viruses
December 2023
Ministry of Health Directorate General for Disease Surveillance and Control Muscat Oman.
Introduction: Severe acute respiratory illness (SARI) is a potentially lethal condition, necessitating thorough medical care. COVID-19 underscored the SARI threat, but other high-risk pathogens require monitoring alongside SARS-CoV-2. Oman instituted a comprehensive testing system to gauge the prevalence of these pathogens between 2017 and 2021, aiding resource allocation and public health responses to potential respiratory pathogen outbreaks.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!